OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) (www.intlstemcell.com), the company which pioneered the creation of human stem cells from unfertilized eggs (called “parthenogenetic stem cells”), provides the following comments regarding draft stem cell research guidelines issued by the National Institutes of Health (NIH) on April 17, 2009.
